Picodya
PrivateLast Round
Grant
Nov 1, 2022
Est. Valuation
$90M
Total Funding Raised
$5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Picodya operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in November 2022.
Picodya is a healthtech company that has developed a syndromic diagnostics platform designed to advance near-patient diagnostics accessibility of molecular and immunoassay multiplexing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Picodya Comparables
Compare Picodya with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Osler Diagnostics | 81% | |
| Cubit Diagnostics | 80% | |
| Vital Bio | 80% |
For institutional investors. Book with your work email.
Picodya Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2022 | ||||
| VC Round | Nov 8, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Picodya Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kibbutz Hatzerim | VC Round |
| Israel Innovation Authority | Grant |
| Israel Innovation Authority | Grant |
| Southern Israel Bridging Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 394% MoM, reaching 1.4K.
- Mar 21, 2025
Attended the Annual LSI USA '25 Emerging Medtech Summit.
For institutional investors. Book with your work email.
Picodya Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Picodya's valuation, stock price, and market status.
Is Picodya a public or private company?
Picodya is a private company.
What is the current stock price of Picodya?
Picodya is a private company, so its shares have no public market price. Caplight tracks Picodya's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Picodya worth (valuation)?
Picodya's valuation is estimated at $90.0M based on funding round data.
Can I buy Picodya stock?
Picodya shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Picodya's last funding round?
Picodya's most recent funding round was Grant on November 1, 2022.
Who are the main investors in Picodya?
Key investors in Picodya include Israel Innovation Authority, Southern Israel Bridging Fund.
Will Picodya IPO soon?
No public IPO plans have been announced for Picodya.
How can I track Picodya secondary market activity?
Caplight tracks bids, offers, and trades in Picodya's shares on secondary markets.